Food and Drug Administration, U.S. Department of Health and Human Services - December 7, 1995
Arthur Whitmore (301) 443-3285
The Food and Drug Administration today approved the first protease inhibitor, a new class of therapy for the treatment of advanced HIV infection. Saquinavir , the new drug, received approval for use in combination with older nucleoside analogue medications only three months after the agency received the application for
Food and Drug Administration, U.S. Department of Health and Human Services - November 20, 1995
Arthur Whitmore; (301) 443-3285
The Food and Drug Administration today announced its accelerated approval for the drug lamivudine, or 3TC , for use in combination with AZT (zidovudine) in treating AIDS and HIV infection. AZT and 3TC are members of the nucleoside analogue class of drug compounds
Food and Drug Administration, U.S. Department of Health and Human Services - September 21, 1995
Betsy Adams; (301) 443-3285
The Food and Drug Administration today proposed ways to make it easier for drugs and medical devices to be studied in patients who are in life-threatening situations and unable to give informed consent for their use. The proposals are designed both to clarify the rules for the testing of unapproved drugs and devices th
Food and Drug Administration, U.S. Department of Health and Human Services - August 23, 1995
Don McLearn; (301) 443-1130
The Food and Drug Administration today proposed a program to give patients more and better information about the prescription drugs they use. The program establishes specific goals and standards that would significantly increase the distribution and quality of written information about prescription drugs to be provided
This information is designed to support, not replace, the relationship that exists between you and your doctor.